Kruppel-like factor-2 CD4+ T cells and intestinal inflammation
Kruppel 样因子 2 CD4 T 细胞和肠道炎症
基本信息
- 批准号:10730990
- 负责人:
- 金额:$ 70.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-01 至 2027-08-31
- 项目状态:未结题
- 来源:
- 关键词:ATAC-seqAntibodiesAntigensAutoimmunityBindingBiologicalBiopsyBypassCD4 Positive T LymphocytesCTLA4 geneCandida albicansCell Differentiation processCell LineageCellsChIP-seqChromatinCoculture TechniquesColitisCrohn&aposs diseaseCytoprotectionDNA BindingDataEngineeringEnterobacteria phage P1 Cre recombinaseEpigenetic ProcessFOXP3 geneGene ExpressionGene Expression ProfileGene Expression ProfilingGene SilencingGerm-FreeHomeostasisHouse miceHumanImmuneImmune ToleranceImmune systemImmunologicsIn VitroIndividualInflammationInflammatoryInflammatory Bowel DiseasesInterleukin-10Intestinal DiseasesIntestinesIrritable Bowel SyndromeKnowledgeKruppel-like transcription factorsLinkLoxP-flanked alleleLymphoid TissueMHC Class II GenesMediatingMemoryMicrobeModelingMolecularMucous MembraneMusOX40Onset of illnessPathogenesisPeripheralPhenotypePhysiologicalProductionPropertyRNARecombinantsRegulatory T-LymphocyteSpecificityT cell differentiationT-Cell ProliferationT-LymphocyteT-Lymphocyte SubsetsTissuesUlcerative ColitisZinc Fingersantimicrobialautoinflammatory diseasescommensal microbesdesignexperiencegut colonizationgut inflammationgut microbiotain vivoinducible gene expressioninsightinterleukin-10 receptormesenteric lymph nodenoveloverexpressionreconstitutionresponseselective expressionsingle-cell RNA sequencingstem
项目摘要
Abstract Mucosal tissues like the intestine harbor trillions of antigenically foreign microbes. Unavoidable
approximation with commensal microbes in this context highlights the need for expanded peripheral immune
tolerance. However, fundamental gaps in knowledge remain as to how this physiological imperative is
achieved. Filling these knowledge gaps have enormous potential to reveal novel insights on the immune-
pathogenesis of inflammatory bowel disease and other human autoinflammatory disorders. Our current
framework for investigating how tolerance expands to accommodate commensal intestinal microbes is
primarily focused on the FOXP3+ suppressive subset of CD4+ T cells called regulatory T cells (Tregs).
However, several inconsistencies also highlight the limitations attributing commensal tolerance exclusively to
FOXP3+ cells. With these considerations, our preliminary studies pivoted to investigate commensal specific
CD4+ T cells, without a FOXP3 bias, using an instructive model whereby CD4+ T cells with commensal
specificity can be precisely identified. Using recombinant Candida albicans to establish intestinal colonization
and tracking endogenous CD4+ T cells with MHC class II tetramers, our initial analysis of gene expression
profiles (single-cell RNA-seq) shows minimal (<5%) Treg differentiation amongst CD4+ cells with commensal
specificity. Instead, RNA profiling showed nearly half of peripheral cells that expand in response to commensal
stimulation are not classified based on expression of other lineage-defining markers, and unified by expression
of the zinc finger transcription factor Kruppel-like factor-2 (KLF2). Antigen-experienced KLF2+ CD4+ T cells are
further shown to potently suppress responder T cell proliferation during in vitro co-culture. The necessity for T
cell expressed KLF2 is further highlighted by spontaneous intestinal inflammation that develops in mice with
conditional KLF2 deficiency in T cells, or the rapid (within 10 days) onset of disease in mice with induced
KLF2-deficiency in CD4+ cells. Intestinal inflammation that occurs in the absence of KLF2+ CD4+ T cells is
triggered by commensal microbes since their elimination using a cocktail of antimicrobials averts intestinal
inflammation, efficiently bypassing the necessity for T cell expressed KLF2. Thus, our overall hypothesis is that
KLF2 identifies a FOXP3-negative immune-suppressive subset of CD4+ T cells essential for sustaining
tolerance to intestinal microbes. Three inter-related aims designed to further develop this potentially ground-
breaking hypothesis are proposed which include establishing the molecular basis for how KLF2+ CD4+ T cells
mediate suppression, and whether KLF2 is necessary and/or sufficient to promote functional suppression (Aim
1), the molecular basis for how KLF2+ CD4+ T cells protect against intestinal inflammation in vivo (Aim 2), along
with gene expression, chromatin accessibility, and KLF2 DNA binding distinctions between KLF2+ CD4+ T cells
compared with FOXP3+ Tregs, and other CD4+ T cell differentiation subsets in intestinal and lymphoid tissue
as a basis for their unique biological functional properties (Aim 3).
摘要像肠道这样的粘膜组织蕴藏着数万亿的抗原性外来微生物。不可避免的
在这种情况下与共生微生物的近似强调了扩大外周免疫的需要
宽容。然而,对于这种生理必要性如何发挥作用,仍然存在根本性的知识空白。
实现了。填补这些知识空白具有揭示免疫相关新见解的巨大潜力。
炎症性肠病和其他人类自身炎症性疾病的发病机制。我们目前的
研究耐受性如何扩展以适应共生肠道微生物的框架
主要关注 CD4+ T 细胞的 FOXP3+ 抑制子集,称为调节性 T 细胞 (Treg)。
然而,一些不一致之处也凸显了将共生耐受完全归因于的局限性。
FOXP3+ 细胞。考虑到这些因素,我们的初步研究转向调查共生特异性
CD4+ T 细胞,没有 FOXP3 偏差,使用指导性模型,其中 CD4+ T 细胞与共生体
可以精确识别特异性。使用重组白色念珠菌建立肠道定植
并用 MHC II 类四聚体追踪内源性 CD4+ T 细胞,这是我们对基因表达的初步分析
谱(单细胞 RNA-seq)显示共生 CD4+ 细胞中 Treg 分化程度极低(<5%)
特异性。相反,RNA 分析显示近一半的外周细胞响应共生体而扩增。
刺激不根据其他谱系定义标记的表达进行分类,并根据表达进行统一
锌指转录因子 Kruppel 样因子 2 (KLF2)。经历过抗原的 KLF2+ CD4+ T 细胞是
进一步显示在体外共培养期间可有效抑制应答 T 细胞增殖。 T的必要性
小鼠中发生的自发性肠道炎症进一步凸显了细胞表达的 KLF2
T 细胞中条件性 KLF2 缺陷,或诱导小鼠发病迅速(10 天内)
CD4+ 细胞中 KLF2 缺陷。在缺乏 KLF2+ CD4+ T 细胞的情况下发生的肠道炎症是
由共生微生物引发,因为使用抗生素混合物消除共生微生物可避免肠道
炎症,有效绕过 T 细胞表达 KLF2 的必要性。因此,我们的总体假设是
KLF2 识别出 FOXP3 阴性的 CD4+ T 细胞亚群,对于维持免疫系统至关重要
对肠道微生物的耐受性。旨在进一步开发这一潜在基础的三个相互关联的目标
提出了突破性假设,其中包括建立 KLF2+ CD4+ T 细胞如何发挥作用的分子基础
介导抑制,以及 KLF2 是否必要和/或足以促进功能性抑制(目标
1),KLF2+ CD4+ T 细胞如何预防体内肠道炎症的分子基础(目标 2),以及
KLF2+ CD4+ T 细胞之间的基因表达、染色质可及性和 KLF2 DNA 结合差异
与肠道和淋巴组织中的 FOXP3+ Tregs 和其他 CD4+ T 细胞分化亚群相比
作为其独特生物功能特性的基础(目标 3)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sing Sing Way其他文献
Sing Sing Way的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sing Sing Way', 18)}}的其他基金
Progesterone induced immune modulation during pregnancy – supplemental research in COVID-19
怀孕期间黄体酮诱导的免疫调节 — COVID-19 的补充研究
- 批准号:
10200397 - 财政年份:2021
- 资助金额:
$ 70.59万 - 项目类别:
Progesterone induced immune modulation during pregnancy
怀孕期间黄体酮诱导的免疫调节
- 批准号:
10192641 - 财政年份:2019
- 资助金额:
$ 70.59万 - 项目类别:
Progesterone induced immune modulation during pregnancy
怀孕期间黄体酮诱导的免疫调节
- 批准号:
10441395 - 财政年份:2019
- 资助金额:
$ 70.59万 - 项目类别:
Progesterone induced immune modulation during pregnancy
怀孕期间黄体酮诱导的免疫调节
- 批准号:
10192641 - 财政年份:2019
- 资助金额:
$ 70.59万 - 项目类别:
Progesterone induced immune modulation during pregnancy – supplemental research in COVID-19
怀孕期间黄体酮诱导的免疫调节 — COVID-19 的补充研究
- 批准号:
10344851 - 财政年份:2019
- 资助金额:
$ 70.59万 - 项目类别:
Progesterone induced immune modulation during pregnancy
怀孕期间黄体酮诱导的免疫调节
- 批准号:
10441395 - 财政年份:2019
- 资助金额:
$ 70.59万 - 项目类别:
Progesterone induced immune modulation during pregnancy
怀孕期间黄体酮诱导的免疫调节
- 批准号:
10653014 - 财政年份:2019
- 资助金额:
$ 70.59万 - 项目类别:
Progesterone induced immune modulation during pregnancy
怀孕期间黄体酮诱导的免疫调节
- 批准号:
9797361 - 财政年份:2019
- 资助金额:
$ 70.59万 - 项目类别:
Progesterone induced immune modulation during pregnancy
怀孕期间黄体酮诱导的免疫调节
- 批准号:
10625933 - 财政年份:2019
- 资助金额:
$ 70.59万 - 项目类别:
Immunological identity redefined by genetically foreign microchimeric cells
外源微嵌合细胞重新定义免疫学特性
- 批准号:
9339521 - 财政年份:2016
- 资助金额:
$ 70.59万 - 项目类别:
相似国自然基金
基于抗原抗体相互作用的抗体定向虚拟设计与筛选
- 批准号:32370697
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
原位疫苗新策略:抗体偶联仿生ROS纳米酶增强巨噬细胞吞噬及抗原交叉呈递效应
- 批准号:32371454
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CD40-CD154共刺激信号介导的TD/TI抗原诱导罗非鱼抗体分泌细胞形成机制的比较研究
- 批准号:32303044
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
靶向CLDN18.2抗体的抗原结合特性对CAR-T抗肿瘤活性的调控机制
- 批准号:82303716
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
抗变构/单体形式的C反应蛋白关键抗原表位199-206抗体在狼疮性肾炎小管间质病变中的作用机制及其靶向治疗研究
- 批准号:82300829
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Understanding the effects of Gender Affirming Hormone Therapy (GAHT) on immune function using a systems immunology approach
使用系统免疫学方法了解性别肯定激素疗法 (GAHT) 对免疫功能的影响
- 批准号:
10749957 - 财政年份:2023
- 资助金额:
$ 70.59万 - 项目类别:
Determining the role of AIRE and AIRE-expressing tumor associated macrophages in tumor growth and immunity
确定 AIRE 和表达 AIRE 的肿瘤相关巨噬细胞在肿瘤生长和免疫中的作用
- 批准号:
10596378 - 财政年份:2023
- 资助金额:
$ 70.59万 - 项目类别:
Evaluation of T follicular regulatory cells as novel cellular targets of cancer immunotherapy
滤泡调节性 T 细胞作为癌症免疫治疗新细胞靶点的评估
- 批准号:
10737557 - 财政年份:2023
- 资助金额:
$ 70.59万 - 项目类别:
Fibroblast dysregulation promotes dermal eosinophilic/Th2 inflammation
成纤维细胞失调促进真皮嗜酸性/Th2炎症
- 批准号:
10725870 - 财政年份:2023
- 资助金额:
$ 70.59万 - 项目类别: